Supramolecular nanomedicine for selective cancer therapy via sequential responsiveness to reactive oxygen species and glutathione.
Sign Up to like & getrecommendations! Published in 2020 at "Biomaterials science"
DOI: 10.1039/d0bm01802c
Abstract: Cancer cells are generally immersed in an oxidative stress environment with a high intracellular reduction level. Thus, nanocarriers with sequential responsiveness to oxidative and reductive species, matching the traits of high oxidation in the tumor… read more here.
Keywords: cancer; sequential responsiveness; supramolecular nanomedicine; cancer therapy ... See more keywords